3rd Real - World Evidence
10th Market Access, Pricing & Reimbursement
- World Congress & EXPO 2023 Americas
- 22nd - 23rd June 2023 | Philadelphia, PA, USA
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
Introduction
The 2 days congress aims to provide a cutting edge, and comprehensive discussions in collaborative format to improve standards and practice for the collection and analysis of data for better decision making for health globally. We are putting together an agenda that focuses on “The significance of RWE in changing the future of drug development and healthcare”. We are gathering high calibre expert speakers to participate and share their knowledge and expertise through Keynote, Presentations and Panel discussions.
We look forward to welcoming you to the RWE World Congress 2023!
GAIN LATEST INSIGHTS ON:
Available Shortly!
INTRODUCTION
Market Access, Pricing & Reimbursement 2023 Americas
In the competitive world of pharmaceutical and medical technology, market access represents the process of understanding the implications
and the impact of a product in the healthcare market where a positive environment and communicating the ‘value’ of your product to the range
of customers who influence uptake will make a big difference.
Only a fully integrated organization can implement the processes, techniques and strategies required to get the right messages to the right
stakeholders at the right time.
The U.S. pharma market is the largest pharmaceutical market worldwide and continues to grow even though there are expected some structural
changes in the healthcare system due to evolving political landscape.
The two-day Market Access, Pricing, and Reimbursement Global Congress 2023 Americas will provide a unique platform and a dynamic
approach to key trends, methodologies, and insights on market access, real-world data, pricing, reimbursement, patient access, and data
collection than the current industry standard is anticipated.
The upcoming 2023 Market Access, Pricing and Reimbursement Global Americas will present a dynamic approach to key trends and insights on market access, health
technology assessment, real-world data, patient access, pricing and reimbursement on the current European landscape.
This year, we are putting together an agenda that addresses “A New Model of Access Strategy for the Next Normal.”. We are gathering together high calibre expert speakers to participate and share their knowledge and expertise through Keynote Presentations and Panel discussions, addressing all aspects of the industry.
We look forward to welcoming you to the MAPR 2023 congress!
Sincerely yours,
Paradigm Global Events Team
Gain insights on:
Who Should Attend
Network with members of the boards, VP’s, Directors, Heads/Chiefs and Senior Managers of leading biopharmaceutical and biotech companies, government, CRO and solution providers involved in:
Collection of high-quality patient-centered data relevant to the design, conduct, and translation of realworld
research.
Applying qualitative patient experience data to make informed study design decisions
Recommendations that may improve the patient centricity of RWE
U.S. diverse multi-payer system
• Reimportation
• Value Proposition & Value Dossier to the R&D
No Spam - You will only receive relevant information on Cell & Gene Therapy and Stem Cell & Regenerative Medicines, and events updates.
Take Advantage of the Super Early Bird Discount. Group Discounts Also Available.